Evaluation of serum NT-pCNP as a diagnostic and prognostic biomarker for sepsis in dogs

Journal of Veterinary Internal Medicine

Volumn 25, Issue 3, 2011, Pages 453-459

  Declue, A E ^a   Osterbur, K ^a   Bigio, A ^a,c   Sharp, C R ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Immunology; Infection; Systemic inflammatory response syndrome; Veterinary

Indexed keywords

BIOLOGICAL MARKER; NATRIURETIC PEPTIDE TYPE C;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE CONTROL STUDY; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; PROSPECTIVE STUDY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; NATRIURETIC PEPTIDE, C-TYPE; PROSPECTIVE STUDIES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALIA; CANIS FAMILIARIS;

EID: 79955512653     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.0713.x     Document Type: Article

References (50)

1. Rau S, Kohn B, Richter C, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol 2007;36:253-260.
2. Luschini MA, Fletcher DJ, Schoeffler GL. Incidence of ionized hypocalcemia in septic dogs and its association with morbidity and mortality: 58 cases (2006-2007). J Vet Emerg Crit Care (San Antonio) 2010;20:406-412.
3. Hauptmann J, Walshaw R, Olivier N. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg 1997;26:393-397.
4. Suga S, Nakao K, Itoh H, et al. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system." J Clin Invest 1992;90:1145-1149.
5. Suga S, Itoh H, Komatsu Y, et al. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993;133:3038-3041.
6. Kubo A, Isumi Y, Ishizaka Y, et al. C-type natriuretic peptide is synthesized and secreted from leukemia cell lines, peripheral blood cells, and peritoneal macrophages. Exp Hematol 2001;29:609-615.
7. Veron W, Lesouhaitier O, Pennanec X, et al. Natriuretic peptides affect Pseudomonasaeruginosa and specifically modify lipopolysaccharide biosynthesis. FEBS J 2007;274:5852-5864.
8. Veron W, Orange N, Feuilloley MG, et al. Natriuretic peptides modify Pseudomonas fluorescens cytotoxicity by regulating cyclic nucleotides and modifying LPS structure. BMC Microbiol 2008;8:114.
9. Hama N, Itoh H, Shirakami G, et al. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994;198:1177-1182.
10. Del Ry S, Cabiati M, Stefano T, et al. Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients. Regul Pept 2011;166:15-20.
11. Prickett TC, Yandle TG, Nicholls MG, et al. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun 2001;286:513-517.
12. Palmer SC, Prickett TC, Espiner EA, et al. Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension 2009;54:612-618.
13. Tawaragi Y, Fuchimura K, Tanaka S, et al. Gene and precursor structures of human C-type natriuretic peptide. Biochem Biophys Res Commun 1991;175:645-651.
14. Wu C, Wu F, Pan J, et al. Furin-mediated processing of pro-C-type natriuretic peptide. J Biol Chem 2003;278:25847-25852.
15. Okano S, Yoshida M, Fukushima U, et al. Usefulness of systemic inflammatory response syndrome criteria as an index for prognosis judgement. Vet Rec 2002;150:245-246.
16. Giunti M, Peli A, Battilani M, et al. Evaluation of CALC-I gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) 2010;20:523-527.
17. Iris K, Leontides LS, Mylonakis ME, et al. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection. Res Vet Sci 89:174-178.
18. Matijatko V, Kis I, Torti M, et al. Septic shock in canine babesiosis. Vet Parasitol 2009;162:263-270.
19. Wilkins P, Otto C, Baumgardner J, et al. Acute lung injury and acute respiratory distress syndromes in veterinary medicine: Consensus definitions: The Dorothy Russell Havemeyer working group on ALI and ARDS in veterinary medicine. J Vet Emergency Crit Care 2007;17:333-339.
20. Nemec A, Pavlica Z, Svete AN, et al. Lack of soluble tumor necrosis factor alpha receptor 1 and 2 and interleukin-1beta compartmentalization in lungs of mice after a single intratracheal inoculation with live Porphyromonas gingivalis. Exp Lung Res 2009;35:605-620.
21. Volakli E, Spies C, Michalopoulos A, et al. Infections of respiratory or abdominal origin in ICU patients: What are the differences? Crit Care 2010;14:R32.
22. Sheu CC, Gong MN, Zhai R, et al. The influence of infection sites on development and mortality of ARDS. Intensive Care Med 2010;36:963-970.
23. Cavaillon JM, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006;12:151-170.
24. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996;154:617-624.
25. Matute-Bello G, Frevert CW, Kajikawa O, et al. Septic shock and acute lung injury in rabbits with peritonitis: Failure of the neutrophil response to localized infection. Am J Respir Crit Care Med 2001;163:234-243.
26. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, et al. Molecular signatures of sepsis: Multiorgan gene expression profiles of systemic inflammation. Am J Pathol 2001;159:1199-1209.
27. Schein M, Wittmann DH, Holzheimer R, et al. Hypothesis: Compartmentalization of cytokines in intraabdominal infection. Surgery 1996;119:694-700.
28. Martineau L, Shek PN. Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis. Crit Care Med 2000;28:788-794.
29. Scheingraber S, Bauerfeind F, Bohme J, et al. Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis. Am J Surg 2001;181:301-308.
30. Whitehead Z, Sharp CR, DeClue AE. Plasma nitric oxide concentrations in dogs with sepsis and NSIRS. International Veterinary Emergency and Critical Care Symposium, Phoenix, AZ, 2008.
31. Sharp CR, Chang CH, DeClue AE. Inflammatory biomarkers for canine sepsis. The American College of Veterinary Internal Medicine Forum, Anaheim, CA, 2010.
32. Harmon MW, DeClue AE, Chang CH, Sharp CR. Inflammatory profiles of dogs with sepsis and NSIRS at hospital presentation. International Veterinary Emergency and Critical Care Symposium, San Antonio, TX, 2010.
33. Dickinson AE, Shaw SP, de Laforcade AM, Kjelgaard-Hansen M. Use of an endotoxin activity assay to identify infection and evaluate outcome in canine ICU patients. International Veterinary Emergency and Critical Care Symposium, Chicago, IL, 2009.
34. de Laforcade A, Freeman L, Shaw S, et al. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003;17:674-679.
35. Kenney EM, Rozanski EA, Rush JE, et al. Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J Am Vet Med Assoc 2010;236:83-87.
36. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000;217:1500-1504.
37. Kuzi S, Aroch I, Peleg K, et al. Canine procalcitonin messenger RNA expression. J Vet Diagn Invest 2008;20:629-633.
38. Jacobson L, Lobetti R, Becker P, et al. Nitric oxide metabolites in naturally occurring canine babesiosis. Vet Parasitol 2002;104:27-41.
39. Kjelgaard-Hansen M, Wiinberg B, Aalbaek B, et al. Endotoxin activity in whole blood measured by neutrophil chemiluminescence is applicable to canine whole blood. Comp Immunol Microbiol Infect Dis 2008;31:477-485.
40. Dabrowski R, Kostro K, Lisiecka U, et al. Usefulness of C-reactive protein, serum amyloid A component, and haptoglobin determinations in bitches with pyometra for monitoring early post-ovariohysterectomy complications. Theriogenology 2009;72:471-476.
41. Gebhardt C, Hirschberger J, Rau S, et al. Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care (San Antonio) 2009;19:450-458.
42. Rogers CL, Rozanski EA. Von willebrand factor antigen concentration in dogs with sepsis. J Vet Intern Med 2010;24:228-230.
43. Gardner IA, Greiner M. Receiver-operating characteristic curves and likelihood ratios: Improvements over traditional methods for the evaluation and application of veterinary clinical pathology tests. Vet Clin Pathol 2006;35:8-17.
44. Torab FC, Abu-Zidan FM, Al-Salam S, et al. Peritoneal resorption capacity for the inflammatory mediators in acute experimental Staphylococcus aureus peritonitis. Ulus Travma Acil Cerrahi Derg 2009;15:330-336.
45. Humm KR, Boag AK, House AK. TNF-alpha levels in the serum and abdominal fluid of dogs with septic peritonitis. International Veterinary Emergency and Critical Care Symposium, Phoenix, AZ, 2008.
46. Ruaux CG, Pennington HL, Worrall S, et al. Tumor necrosis factor-alpha at presentation in 60 cases of spontaneous canine acute pancreatitis. Vet Immunol Immunopathol 1999;72:369-376.
47. Rivas AL, Tintle L, Kimball ES, et al. A canine febrile disorder associated with elevated interleukin-6. Clin Immunol Immunopathol 1992;64:36-45.
48. Itoh H, Horiuchi Y, Nagasaki T, et al. Evaluation of immunological status in tumor-bearing dogs. Vet Immunol Immunopathol 2009;132:85-90.
49. Mohamed A, Matsumoto Y, Yoshihara K, et al. Establishment of a sandwich enzyme linked immunosorbent assay for canine interleukin-8. J Vet Med Sci 1997;59:39-41.
50. Hegemann N, Wondimu A, Kohn B, et al. Cytokine profile in canine immune-mediated polyarthritis and osteoarthritis. Vet Comp Orthop Traumatol 2005;18:67-72.